[go: up one dir, main page]

Follow
Sandra O'Toole
Sandra O'Toole
Clinical Professor Sydney University and Staff Specialist Tissue Pathology Royal Prince Alfred Hospital
Verified email at garvan.org.au
Title
Cited by
Cited by
Year
A single-cell and spatially resolved atlas of human breast cancers
SZ Wu, G Al-Eryani, DL Roden, S Junankar, K Harvey, A Andersson, ...
Nature genetics 53 (9), 1334-1347, 2021
14662021
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311-335, 2017
9042017
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235-251, 2017
8042017
ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
M van Geldermalsen, Q Wang, R Nagarajah, AD Marshall, A Thoeng, ...
Oncogene 35 (24), 3201-3208, 2016
6802016
Molecular biology of lung cancer
WA Cooper, DCL Lam, SA O’Toole, JD Minna
Journal of thoracic disease 5 (Suppl 5), S479, 2013
5142013
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
AS Cazet, MN Hui, BL Elsworth, SZ Wu, D Roden, CL Chan, JN Skhinas, ...
Nature communications 9 (1), 2897, 2018
4532018
Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
SZ Wu, DL Roden, C Wang, H Holliday, K Harvey, AS Cazet, KJ Murphy, ...
The EMBO journal 39 (19), e104063, 2020
4292020
PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality
E López‐Knowles, SA O'Toole, CM McNeil, EKA Millar, MR Qiu, P Crea, ...
International journal of cancer 126 (5), 1121-1131, 2010
4112010
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel
EKA Millar, PH Graham, SA O'Toole, CM McNeil, L Browne, AL Morey, ...
Journal of clinical oncology 27 (28), 4701-4708, 2009
3882009
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
CG Fedele, LM Ooms, M Ho, J Vieusseux, SA O'Toole, EK Millar, ...
Proceedings of the National Academy of Sciences 107 (51), 22231-22236, 2010
3462010
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma
WA Cooper, T Tran, RE Vilain, J Madore, CI Selinger, M Kohonen-Corish, ...
Lung cancer 89 (2), 181-188, 2015
3382015
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
C Denkert, S Wienert, A Poterie, S Loibl, J Budczies, S Badve, ...
Modern Pathology 29 (10), 1155-1164, 2016
3232016
Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome
RK Beckers, CI Selinger, R Vilain, J Madore, JS Wilmott, K Harvey, ...
Histopathology 69 (1), 25-34, 2016
2712016
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
EC Paver, WA Cooper, AJ Colebatch, PM Ferguson, SK Hill, T Lum, ...
Pathology 53 (2), 141-156, 2021
2532021
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
EY Tan, M Yan, L Campo, C Han, E Takano, H Turley, I Candiloro, ...
British journal of cancer 100 (2), 405-411, 2009
2482009
Diagnosis of fusion genes using targeted RNA sequencing
EE Heyer, IW Deveson, D Wooi, CI Selinger, RJ Lyons, VM Hayes, ...
Nature communications 10 (1), 1388, 2019
2282019
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells
F Hochgräfe, L Zhang, SA O'Toole, BC Browne, M Pinese, A Porta Cubas, ...
Cancer research 70 (22), 9391-9401, 2010
2192010
Cytoplasmic localization of β-catenin is a marker of poor outcome in breast cancer patients
E López-Knowles, SJ Zardawi, CM McNeil, EKA Millar, P Crea, ...
Cancer epidemiology, biomarkers & prevention 19 (1), 301-309, 2010
2192010
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers
M Yan, N Jene, D Byrne, EKA Millar, SA O'Toole, CM McNeil, GJ Bates, ...
Breast Cancer Research 13 (2), R47, 2011
2172011
Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer
SA O'Toole, DA Machalek, RF Shearer, EKA Millar, R Nair, P Schofield, ...
Cancer research 71 (11), 4002-4014, 2011
2022011
The system can't perform the operation now. Try again later.
Articles 1–20